Regardless of Nestle or retail sales, if there is going to be a monster payoff here the nausea trial for chemo patients will be it.
TAUG certainly has the ability to be a winner based on retail for sure, maybe even have a $100 million or more market cap from it. But the elephant is the pharma.
Nestle bought Skinny Cow when it was a micro cap and turned that into a very profitable brand
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.